ArticlePLoS biology2022
Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link.
Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Stochastic colonization and host-to-host transmission shape gut bacterial variability.bioRxiv : the preprint server for biology · 2026Article
- Expanding AMR surveillance with the WHO's AWaRe classification: a nationwide occupational cohort study in Taiwan (2004-2020).BMJ public health · 2026Article
- Real-TimeACS biomaterials science & engineering · 2025Article
- Article
- FeScientific reports · 2025Article
- A nationwide cohort study on pneumonia infections among agriculture and healthcare workers in Taiwan.Epidemiology and infection · 2024Article
- Tailored culture strategies to promote antimicrobial secondary metabolite production in Diaporthe caliensis: a metabolomic approach.Microbial cell factories · 2024Article
- Advancing global antibiotic research, development and access.Nature medicine · 2024Review
- One Health WASH: an AMR-smart integrative approach to preventing and controlling infection in farming communities.BMJ global health · 2023Article
- The antimicrobial resistance crisis needs action now.PLoS biology · 2022Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
Despite high mortality and morbidity, drug-resistant bacterial infections remain the forgotten pandemic. We argue for strengthening of diagnostics, WASH (water, sanitation, and hygiene) and infection prevention and control to reduce drug-resistant infections, as an integral part of sustainable high-quality health services, particularly in low- and middle-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.